The plasma from severe COVID-19 patients similarly exhibited increased IL-6, IL-10, and MCP-1 levels, but these levels were not as high as those in patients with CRS from other causes such as sepsis and burns (29). This evidence concerns the gene CCL2 and congenital rubella syndrome.